JOURNAL OF BACTERIOLOGY AND VIROLOGY ISSN:1598-2467(Print) 2093-0429(Online)

Garcia-Suarez Mdel M, Vazquez F, Mendez FJ. Streptococcus pneumoniae virulence factors and their clinical impact: An update. Enferm Infecc Microbiol Clin. 2006;24(8):512-517.

Ganaie F, Maruhn K, Li C, Porambo RJ, Elverdal PL, Abeygunwardana C, et al. Structural, Genetic, and Serological Elucidation of Streptococcus pneumoniae Serogroup 24 Serotypes: Discovery of a New Serotype, 24C, with a Variable Capsule Structure. J Clin Microbiol. 2021;59(7):e0054021.

Ganaie F, Saad JS, McGee L, van Tonder AJ, Bentley SD, Lo SW, et al. A New Pneumococcal Capsule Type, 10D, is the 100th Serotype and Has a Large cps Fragment from an Oral Streptococcus. mBio. 2020:11(3);e00937-20.

van Hoek AJ, Andrews N, Waight PA, George R, Miller E. Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes. PLoS One. 2012;7(7):e39150.

Bhattacharya S, Kanungo R, Natarajan MK, Mahalakshmi VN, Srinivasan K. Unimicrobial appendicitis due to non-vaccine serotype of streptococcus pneumoniae: Implications for and management and prevention. Indian J Med Microbiol. 2001;19(2):59-61.

Romero-Steiner S, Pais L, Holder P, Carlone GM, Keyserling HL. 1995. Opsonophagocytosis of Streptococcus pneumoniae as an indicator of functional antibody activity in adults vaccinated with a 23-valent polysaccharide vaccine. ASM meeting (Abstr. E-42).

Joma BH, Siwapornchai N, Vanguri VK, Shrestha A, Roggensack SE, Davidson BA, et al. A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age. Infect Immun. 2021;89(8):e0047120.

Chiavolini D, Pozzi G, Ricci S. Animal models of Streptococcus pneumoniae disease. Clin Microbiol Rev. 21(4):666-685.

Jang AY, Seo HS, Lin S, Chung GH, Kim HW, Lim S, et al. Molecular characterization of pneumococcal surface protein K, a potential pneumococcal vaccine antigen. Virulence. 2017;8(6):875-890.

Yau B, Too LK, Ball HJ, Hunt NH. TIGR4 strain causes more severe disease than WU2 strain in a mouse model of Streptococcus pneumoniae meningitis: a common pathogenic role for interferon-gamma. Microbes Infect. 2017;19(7-8):413-421.

Jeong DG, Jeong ES, Seo JH, Heo SH, Choi YK. Difference in Resistance to Streptococcus pneumoniae Infection in Mice. Lab Anim Res. 2011;27(2):91-98.

Choi SS, van Unen V, Zhang H, Rustagi A, Alwahabi SA, Santos AJM, et al. Organoid modeling of lung-resident immune responses to SARS-CoV-2 infection. Res Sq. 2023;rs.3.rs-287069.

Hughes T, Dijkstra KK, Rawlins EL, Hynds RE. Open questions in human lung organoid research. Front Pharmacol. 2023;13:1083017.

Pan Y, Cui H, Song Y. Organoid drug screening report for a non-small cell lung cancer patient with EGFR gene mutation negativity: A case report and review of the literature. Front Oncol. 2023;13:1109274.

Duarte RRR, Copertino DC Jr, Iniguez LP, Marston JL, Bram Y, Han Y, et al. Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry. Mol Med. 2021;27(1):105.

Liberti DC, Morrisey EE. Organoid models: assessing lung cell fate decisions and disease responses. Trends Mol Med. 2021;27(12):1159-1174.

Tindle C, Fuller M, Fonseca A, Taheri S, Ibeawuchi SR, Beutler N, et al. Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19. Elife. 2021;10:e66417.

Han L, Zhao S, Yu F, Rong Z, Lin Y, Chen Y. Generation of human embryonic stem cell-derived lung organoids. STAR Protoc. 2022;3(2):101270.

Talbot UM, Paton AW, Paton JC. Uptake of Streptococcus pneumoniae by respiratory epithelial cells. Infect Immun. 1996;64(9):3772-3777.

Ladhani SN, Collins S, Djennad A, Sheppard CL, Borrow R, Fry NK, et al. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. Lancet Infect Dis. 2018;18(4):441-451.

Melin M, Trzcinski K, Antonio M, Meri S, Adegbola R, Kaijalainen T, et al. Serotype-related variation in susceptibility to complement deposition and opsonophagocytosis among clinical isolates of Streptococcus pneumoniae. Infect Immun. 2010;78(12):5252-5261.

Melin M, Trzcinski K, Meri S, Kayhty H, Vakevainen M. The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement. Infect Immun. 2010;78(12):5262-5270.

Abruzzo AR, Aggarwal SD, Sharp ME, Bee GCW, Weiser JN. Serotype-Dependent Effects on the Dynamics of Pneumococcal Colonization and Implications for Transmission. mBio. 2022;13(2):e0015822.

Jaeger B, Schupp JC, Plappert L, Terwolbeck O, Artysh N, Kayser G, et al. Airway basal cells show a dedifferentiated KRT17(high)Phenotype and promote fibrosis in idiopathic pulmonary fibrosis. Nat Commun. 2022;13(1):5637.

Stroulios G, Brown T, Moreni G, Kondro D, Dei A, Eaves A, et al. Apical-out airway organoids as a platform for studying viral infections and screening for antiviral drugs. Sci Rep. 2022;12(1):7673.

Schmeck B, Moog K, Zahlten J, van Laak V, N'Guessan PD, Opitz B, et al. Streptococcus pneumoniae induced c-Jun-N-terminal kinase- and AP-1 -dependent IL-8 release by lung epithelial BEAS-2B cells. Respir Res. 2006;7(1):98.

Rosseau S, Hocke A, Mollenkopf H, Schmeck B, Suttorp N, Kaufmann SH, et al. comparative transcriptional profiling of the lung reveals shared and distinct features of Streptococcus pneumoniae and influenza A virus infection. Immunology. 2007;120(3):380-391.